Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Emergent Evaluation and Management Of Pelvic Inflammatory Disease

By ACEP Now | on January 1, 2010 | 0 Comment
CME CME Now
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Learning Objectives

After reading this article, the physician should be able to:

You Might Also Like
  • Critical Issues in the Initial Evaluation and Management of Patients Presenting to the Emergency Department in Early Pregnancy
  • Evaluation and Management of Suspected Appendicitis
  • Critical Decisions: Pediatric Sickle Cell Disease – Part Two
Explore This Issue
ACEP News: Vol 29 – No 01 – January 2010
  • Diagnose pelvic inflammatory disease (PID) using history and physical examination, as well as maintain a low threshold for diagnosis of subclinical cases.
  • Institute appropriate antibiotic therapy for confirmed and suspected cases of PID.
  • Identify those patients with PID who will benefit from further evaluation (e.g., gynecology consultation, ultrasonography, or laparoscopy).
  • Educate patients concerning the risk factors for developing recurrent PID, along with the complications associated with untreated disease.

Pelvic inflammatory disease is an infectious process involving a woman’s upper genital tract. While the infection may be limited to the uterus, fallopian tubes, and/or ovaries, it may also become extensive and involve the neighboring pelvic organs.

Pelvic inflammatory disease (PID) is the most frequent gynecologic cause of emergency department visits, approaching 350,000 per year.1 Complications of untreated PID are devastating and include ectopic pregnancy, infertility, and chronic pelvic pain.

Therefore, it is necessary for emergency physicians to diagnose and initiate appropriate antibiotic therapy in patients with PID in order to achieve optimal patient outcomes.

Pathogenesis

PID affects the female upper genital tract, with infection leading to endometritis, salpingitis, oophritis, pelvic peritonitis, and perihepatits.2

The dominant organism in a healthy woman’s vaginal flora is Lactobacillus acidophilus, though species of streptococci, staphylococci, and enterobacteriaceae are also present.3

While the endocervical canal typically functions as a barrier between the potentially pathogenic vaginal bacteria and the sterile female upper reproductive tract, PID results from a disruption of both the vaginal flora and the endocervical canal.

Risk factors for the development of PID include a prior episode of PID,4 a high number of sexual partners,5 use of nonbarrier contraception,6 and earlier age at first intercourse.7

Microbiology

Epidemiologic studies suggest that sexually transmitted diseases are the cause of community-acquired PID.

The most common initiating pathogens are Neisseria gonorrhoeae and Chlamydia trachomatis, although a specific inciting organism is not determined in approximately 20% of PID cases.8

N. gonorrhoeae was the first identified cause of PID and currently accounts for approximately 40% of PID cases overall, though there is considerable geographic variance.9 C. trachomatis was first recognized as an organism responsible for PID in the mid-1970s and is identified in 50% of cases.10

While the vast majority of gonorrheal and chlamydial infections are asymptomatic, it is estimated that approximately 15% of cervical infections from these organisms ultimately result in PID.11

Pages: 1 2 3 4 5 6 7 | Single Page

Topics: Abdominal and GastrointestinalAntibioticClinical ExamClinical GuidelineCMEDiagnosisEducationEmergency MedicineEmergency PhysicianImaging and UltrasoundPainPractice ManagementProcedures and SkillsTechnologyUrogenital

Related

  • Can This Patient Leave Against Medical Advice?

    March 10, 2025 - 0 Comment
  • Emergency Physicians of the Sandwich Generation Face Unique Challenges

    March 10, 2025 - 0 Comment
  • Texas Hospitals Now Must Ask About Immigration Status

    March 10, 2025 - 0 Comment

Current Issue

ACEP Now May 03

Read More

About the Author

ACEP Now

View this author's posts »

No Responses to “Emergent Evaluation and Management Of Pelvic Inflammatory Disease”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603